Magazine article Medical Economics

Letters to the Editors

Magazine article Medical Economics

Letters to the Editors

Article excerpt

Don't let liability carriers hamstring your defense

Your article "Malpractice: Why you may be forced to settle" [Feb. 22] did not resonate well with me. You failed to point out the alternative to the large, commercial insurance carriers whose cost cutting consigns doctors to a second-rate defense: physician-owned and operated malpractice insurance companies.

Their strengths are exactly what your article advised us to look for when buying malpractice coverage: they spare no expense to defend doctors-especially in obtaining topnotch medical experts; they will not settle without your consent; and they offer the best attorney panel available and a local, knowledgeable claims staff for prompt answers to your questions.

Money spent for premiums becomes insignificant when you have such a partner on your side at times of crisis.

R.W. Keller, MD

Anchorage, AK

In describing how malpractice carriers pressure defense lawyers to keep expenses down, attorney Rick Evans says: "When you're being nickel-and-dimed by some number cruncher at the insurance company, it prevents you from giving your client your best representation" Read that sentence again, but this time use "patient" instead of "client;' and "care" in place of "representation. " Sound familiar? It's the most serious problem facing physicians today: managed care.

We can learn a lot from lawyers' proactive response to their problem of "managed law." They are successfully taking insurance companies to court. It's time for us to act as well!

Rodolfo Martinez-Ferrate, MD

Gallup, NM

Speaking out against therapeutic cloning

It was inappropriate to publish a letter from Sen. Arlen Specter campaigning for therapeutic cloning ["Letters to the Editors," April 12]. Where's the letter from a senator presenting the other side of the issue?

John M. Lawns, MD

Indianapolis

Editor's Note: Although we haven't received a letter from a senator speaking out against therapeutic cloning, we understand the desire to hear the other side. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.